Rixin Chen

2.0k citations

33 papers · 910 indexed · 1 hit paper · h-index 11

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
- Epigenetics and DNA Methylation

Papers in ⓘ

Pulmonary and Respiratory Medicine 15
- Lung Cancer Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 5
- Gastric Cancer Management and Outcomes 4
Molecular Biology 14
- RNA modifications and cancer 9
- Circular RNAs in diseases 5

Co-authors: Dan Xie (9 shared papers)Feng‐Wei Wang (6 shared papers)Kai Han (4 shared papers)Jiewei Chen (4 shared papers)Xin Chen (2 shared papers)Olivier Déas (1 shared paper)Jing‐Ping Yun (2 shared papers)Xin‐Yuan Guan (2 shared papers)
Journals: Annals of Surgical Oncology (4 papers)Cell Death and Disease (2 papers)Frontiers in Oncology (2 papers)Cancer Science (2 papers)Molecular Cancer (2 papers)
Partner nations: China Hong Kong United Kingdom

In The Last Decade

Rixin Chen

26 papers receiving 907 citations

Hit Papers

align trajectories log scale

N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis 2019 · 537 citations

Peers

Countries citing papers authored by Rixin Chen

Since Specialization

Citations

This map shows the geographic impact of Rixin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rixin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rixin Chen more than expected).

Fields of papers citing papers by Rixin Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rixin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rixin Chen. The network helps show where Rixin Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Rixin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rixin Chen Line = papers co-authored together Rixin Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Nature Communications ·Rixin Chen, Xin Chen, Liangping Xia, Jiaxing Zhang, Zhizhong Pan, Xiaodan Ma, Kai Han, Jiewei Chen, Jean-Gabrie Judde, Olivier Déas, Feng Wang, Ning‐Fang Ma, Xin‐Yuan Guan, Jing‐Ping Yun, Feng‐Wei Wang, Rui‐Hua Xu, Dan Xie Hit paper breakdown →	2019	537
2	A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma Molecular Cancer ·Jin‐Ling Duan, Wei Chen, Juanjuan Xie, Mao-Lei Zhang, Run‐Cong Nie, Hu Liang, Jie Mei, Kai Han, Zhicheng Xiang, Feng‐Wei Wang, Kai Teng, Rixin Chen, Minhua Deng, Yixin Yin, Nu Zhang, Dan Xie, Muyan Cai	2022	109
3	m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization Cell Death and Disease ·Ning Wang, Rixin Chen, Minhua Deng, Wensu Wei, Zhaohui Zhou, Ning Kang, Yonghong Li, Xiangdong Li, Yunlin Ye, Jun-hua Wen, Biao Dong, Xuepei Zhang, Zhuowei Liu, Fangjian Zhou	2023	64
4	Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma Drug Resistance Updates ·Shi-Hui Hao, Xiaodan Ma, Li Xu, Jingdun Xie, Zihao Feng, Jiewei Chen, Rixin Chen, Feng‐Wei Wang, Yuhao Tang, Dan Xie, Muyan Cai	2024	31
5	Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway Cancer Science ·Gangjun Yuan, Xin Chen, Jun Lü, Zihao Feng, Siliang Chen, Rixin Chen, Wensu Wei, Fangjian Zhou, Dan Xie	2017	23
6	ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21 Cancer Science ·Minhua Deng, Wensu Wei, Jin‐Ling Duan, Rixin Chen, Ning Wang, Leye He, Yulu Peng, Xiaodan Ma, Zeshen Wu, Jianye Liu, Zhiyong Li, Zhiling Zhang, Lijuan Jiang, Fangjian Zhou, Dan Xie	2021	23
7	LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer Scientific Reports ·Kai Sun, Rixin Chen, Jingzhang Li, Zhanxiong Luo	2022	21
8	FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA Cell Death and Disease ·Minhua Deng, Ning Wang, Zhiyong Li, Rixin Chen, Jin‐Ling Duan, Yulu Peng, Zeshen Wu, Zhiling Zhang, Lijuan Jiang, X.F. Steven Zheng, Dan Xie, Wensu Wei, Zhuowei Liu, Fangjian Zhou	2022	18
9	Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy Signal Transduction and Targeted Therapy ·Rixin Chen, Shuidan Xu, Minhua Deng, Shi-Hui Hao, Jiewei Chen, Xiaodan Ma, Weitao Zhuang, Jinghua Cao, Yongrui Lv, Jin‐Long Lin, Siyu Li, Guibin Qiao, Dan Xie, Feng‐Wei Wang	2024	13
10	Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients Human Vaccines & Immunotherapeutics ·Weitao Zhuang, Jingyu Zhang, Peijian Wei, Zihua Lan, Rixin Chen, Cheng Zeng, Qiuling Shi, Guibin Qiao	2021	12
11	Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies European Radiology ·Yu Ding, Jingyu Zhang, Weitao Zhuang, Zhen Gao, Kaiming Kuang, Dan Tian, Cheng Deng, Hansheng Wu, Rixin Chen, Guojie Lu, Gang Chen, Paolo Mendogni, Marcello Migliore, Min‐Woong Kang, Ryu Kanzaki, Yong Tang, Jiancheng Yang, Qiuling Shi, Guibin Qiao	2022	10
12	KLF16 enhances stress tolerance of colorectal carcinomas by modulating nucleolar homeostasis and translational reprogramming Molecular Therapy ·Xiaodan Ma, Shuidan Xu, Shi-Hui Hao, Kai Han, Jie-Wei Chen, Han Ling, Rixin Chen, Xiaohan Jin, Jinghua Cao, Jin‐Long Lin, Qingjian Ou, Yujing Fang, Zhizhong Z. Pan, Dan Xie, Feng‐Wei Wang	2022	8
13	Minimally invasive surgery vs. open thoracotomy for non-small-cell lung cancer with N2 disease: a systematic review and meta-analysis Frontiers in Medicine ·Songlin Liu, Shaopeng Li, Yong Tang, Rixin Chen, Guibin Qiao	2023	6
14	Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer Lung Cancer ·Shujie Huang, Junhan Wu, Shaopeng Li, Xianglin Li, Ruijie Zeng, Yong Tang, Jiming Tang, Xiaosong Ben, Dongkun Zhang, Liang Xie, Haiyu Zhou, Gang Chen, Sichao Wang, Z. Gao, Hansheng Wu, Rixin Chen, Fangping Xu, Guibin Qiao	2023	6
15	NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance Cell Discovery ·Jinlong Lin, Yixin Yin, Jinghua Cao, Yiyang Zhang, Jie-Wei Chen, Rixin Chen, Bingxu Zou, Cijun Huang, Yongrui Lv, Shuidan Xu, Han Yang, Peng Lin, Dan Xie	2025	6
16	[Observation on therapeutic effect of acupuncture combined with drug for treatment of intestinal metaplasia of chronic atrophic gastritis]. PubMed ·Yong Lu, Jia-Tao Wang, Rixin Chen	2005	5
17	49342 First FASN inhibitor ASC40 to treat acne vulgaris patients: final results form a Phase 2 trial Journal of the American Academy of Dermatology ·Leihong Xiang, Rixin Chen, Liming Wu, Aie Xu, Li He, Jinyan Wang, Yan Lu, Rong Xiao, Lunfei Liu, Yanyan Feng, Jinzi J. Wu	2024	3
18	Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 Molecular Cancer ·Kai Han, Feng‐Wei Wang, Chenhui Cao, Ling Han, Jiewei Chen, Rixin Chen, Zihao Feng, Jie Luo, Xiaohan Jin, Jin‐Ling Duan, Shuman Li, Ning‐Fang Ma, Jing‐Ping Yun, Xin‐Yuan Guan, Zhizhong Pan, Ping Lan, Rui‐Hua Xu, Dan Xie	2021	3
19	Early patient‐reported outcomes after robotic‐assisted versus video‐assisted thoracoscopic lobectomy Thoracic Cancer ·Zihua Lan, Cheng Zeng, Zijie Li, Xin Xia, Aotian Mo, Xianglin Li, Xiaosong Ben, Haiyu Zhou, Cheng Deng, Rixin Chen, Qiuling Shi, Yong Tang, Guibin Qiao	2024	3
20	Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy Annals of Surgical Oncology ·Shujie Huang, Yong Tang, Hansheng Wu, Qiuling Shi, Jiming Tang, Xiaosong Ben, Dongkun Zhang, Liang Xie, Haiyu Zhou, Gang Chen, Sichao Wang, Zhen Gao, Zefeng Xie, Rixin Chen, Guibin Qiao	2023	2

About Rixin Chen

Rixin Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Cancer Research, having authored 33 papers that have together received 910 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Esophageal Cancer Research and Treatment (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Circular RNAs in diseases (5 papers), Lung Cancer Treatments and Mutations (5 papers), Gastric Cancer Management and Outcomes (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (588 citations), Molecular Biology (810 citations), Pulmonary and Respiratory Medicine (92 citations), Immunology (47 citations) and Oncology (49 citations). Rixin Chen has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Dan Xie, Feng‐Wei Wang, Kai Han, Jiewei Chen, Xin Chen, Olivier Déas, Jing‐Ping Yun, Xin‐Yuan Guan, Liangping Xia and Ning‐Fang Ma. Their work appears in journals such as Annals of Surgical Oncology, Cell Death and Disease, Frontiers in Oncology, Cancer Science and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact